Be Gone Sinus Congestion Tm

Oyster Shell Calcium Carbonate, Crude - Goldenseal - Potassium Dichromate

Washington Homeopathic Products
Human Otc Drug
NDC 68428-730

Be Gone Sinus Congestion Tm also known as Oyster Shell Calcium Carbonate, Crude - Goldenseal - Potassium Dichromate is a human otc drug labeled by 'Washington Homeopathic Products'. National Drug Code (NDC) number for Be Gone Sinus Congestion Tm is 68428-730. This drug is available in dosage form of Pellet. The names of the active, medicinal ingredients in Be Gone Sinus Congestion Tm drug includes Goldenseal - 6 [hp_C]/28g Oyster Shell Calcium Carbonate, Crude - 6 [hp_C]/28g Potassium Dichromate - 6 [hp_C]/28g . The currest status of Be Gone Sinus Congestion Tm drug is Active.

Drug Information:

Drug NDC:	68428-730
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Be Gone Sinus Congestion Tm
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base:	Be Gone Sinus Congestion
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix:	TM
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Oyster Shell Calcium Carbonate, Crude - Goldenseal - Potassium Dichromate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Washington Homeopathic Products
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Pellet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	GOLDENSEAL - 6 [hp_C]/28g OYSTER SHELL CALCIUM CARBONATE, CRUDE - 6 [hp_C]/28g POTASSIUM DICHROMATE - 6 [hp_C]/28g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	28 Feb, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	16 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Washington Homeopathic Products
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	ZW3Z11D0JV 2E32821G6I T4423S18FM
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
68428-730-29	1 BOTTLE, PLASTIC in 1 BOX (68428-730-29) / 28 g in 1 BOTTLE, PLASTIC (68428-730-14)	28 Feb, 2013	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Be Gone Sinus Congestion Tm

Oyster Shell Calcium Carbonate, Crude - Goldenseal - Potassium Dichromate

Pellet
Washington Homeopathic Products
NDC: 68428-730

Purpose:

Uses to relieve the symptoms of congested sinuses and headaches relating to congested sinuses.

Product Elements:

Be gone sinus congestion tm oyster shell calcium carbonate, crude - goldenseal - potassium dichromate sucrose lactose oyster shell calcium carbonate, crude oyster shell calcium carbonate, crude goldenseal goldenseal potassium dichromate dichromate ion white

Indications and Usage:

Indications indications: calc carb - overwork hydrastis - sinuses kali bic - sinuses

Warnings:

Stop use and ask doctor if symptoms persist or recur, discontinue use. if pregnant or nursing a baby, consult a licensed practitioner before using this product.

Dosage and Administration:

Directions adults 2 pellets every 3 hours for 2 days. then 2 pellets morning and night for 2 weeks. children: 1 pellet. repeat as necessary.

Package Label Principal Display Panel:

Principal display panel be g one tm sinus congesion label be g one tm sinus congestion box image of label image of box

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.